Laurie Stelzer Chief Financial Officer

Laurie has over 25 years of experience supporting the finance functions for biopharma companies, most recently as CFO of ReNAgade Therapeutics. Previously, she served as CFO of Arena Pharmaceuticals, where she helped lead the growth of the company toward its $6.7B acquisition by Pfizer. Laurie was also CFO at Halozyme Therapeutics, where she led the company’s finance, IT, business development, and project management functions. She also held senior management roles at Shire, including Senior Vice President of Finance, Division CFO for the Regenerative Medicine Division, and Head of Investor Relations. Laurie began her biotech career at Amgen, where she spent 15 years in positions of increasing responsibility, holding multiple roles in finance, global commercial operations, treasury and international/emerging markets. She received her B.S. in Accounting from Arizona State University and her M.B.A. from the Anderson School of Management at the University of California, Los Angeles.